Perhaps the most compelling evidence of the significance of CRYBB2 for retina neuroprotection has been that its intravitreal injection at the time of IOP elevation improves retinal ganglion cell survival in a rat model of glaucoma combined with mass spectrometry-based proteomics experiments [58]. The gene discussed is CRYBB2; the disease is glaucoma.